Merck KGaA (FRA:MRK) has been assigned a €110.00 ($120.88) target price by research analysts at Goldman Sachs Group Inc in a note issued to investors on Friday. The firm currently has a “neutral” rating on the healthcare company’s stock.

A number of other research firms have also recently issued reports on MRK. Nord/LB set a €114.00 ($125.27) price target on shares of Merck KGaA and gave the company a “buy” rating in a research note on Thursday, March 9th. Commerzbank Ag set a €109.00 ($119.78) price target on shares of Merck KGaA and gave the company a “neutral” rating in a research note on Thursday, March 9th. Independent Research GmbH set a €110.00 ($120.88) price target on shares of Merck KGaA and gave the company a “neutral” rating in a research note on Thursday, March 9th. Citigroup Inc set a €116.00 ($127.47) price target on shares of Merck KGaA and gave the company a “buy” rating in a research note on Wednesday, March 1st. Finally, BNP Paribas set a €114.00 ($125.27) price target on shares of Merck KGaA and gave the company a “buy” rating in a research note on Tuesday, February 28th. One analyst has rated the stock with a sell rating, fifteen have given a hold rating and six have given a buy rating to the stock. Merck KGaA has a consensus rating of “Hold” and an average target price of €109.29 ($120.09).

Analyst Recommendations for Merck KGaA (FRA:MRK)

Merck KGaA (FRA:MRK) traded down 0.555% during trading on Friday, hitting €107.898. 890 shares of the stock traded hands. Merck KGaA has a 52-week low of €80.99 and a 52-week high of €115.00. The stock has a market cap of €46.91 billion and a P/E ratio of 28.796. The stock has a 50 day moving average price of €107.69 and a 200-day moving average price of €101.54.

ILLEGAL ACTIVITY NOTICE: This report was first published by American Banking News and is the property of of American Banking News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/05/19/merck-kgaa-mrk-given-a-110-00-price-target-at-goldman-sachs-group-inc.html.

About Merck KGaA

.

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.